Results 31 to 40 of about 322,217 (303)

Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support [PDF]

, 2004
Background - The mechanisms underlying the variation in collateral formation between patients, even with similar patterns of coronary artery disease, remain unclear.
Bucknall, CA, Meng, Y G, Redwood, SR, Pearson, JD, Redwood, S R, Edwards, R J, Lambiase, PD, Marber, MS, Edwards, RJ, Anthopoulos, P, Rahman, S, Lambiase, P D, Meng, YG, Pearson, J D, Marber, M S; id_orcid, Bucknall, C A   +15 more
core   +1 more source

Size-Based and Non-Affinity Based Microfluidic Devices for Circulating Tumor Cell Enrichment and Characterization [PDF]

, 2016
Circulating Tumor Cells (CTCs) are tumor cells found in cancer patients’ peripheral blood. Enumeration of CTCs can provide prognosis information for cancer management (Cristofanilli et al., N Engl J Med 351(8):781–791, 2004; Cohen et al., J Clin Oncol 26(
Richard J. Cote, Cote, Richard J, Zheng Ao, Datar, Ram H, Kamran Moradi, Moradi, Kamran, Ram H. Datar, Ao, Zheng   +7 more
core   +1 more source

In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood

Frontiers in Cell and Developmental Biology, 2023
Background: Platelets are active players in hemostasis, coagulation and also tumorigenesis. The cross-talk between platelets and circulating tumor cells (CTCs) may have various pro-cancer effects, including promoting tumor growth, epithelial-mesenchymal ...
Zahra Eslami-S, Zahra Eslami-S, Zahra Eslami-S, Luis Enrique Cortés-Hernández, Luis Enrique Cortés-Hernández, Luis Enrique Cortés-Hernández, Ilias Glogovitis, Ilias Glogovitis, Ilias Glogovitis, Mafalda Antunes-Ferreira, Mafalda Antunes-Ferreira, Mafalda Antunes-Ferreira, Silvia D’Ambrosi, Silvia D’Ambrosi, Silvia D’Ambrosi, Keerthi Kurma, Keerthi Kurma, Keerthi Kurma, Françoise Garima, Françoise Garima, Françoise Garima, Laure Cayrefourcq, Laure Cayrefourcq, Laure Cayrefourcq, Myron G. Best, Myron G. Best, Myron G. Best, Danijela Koppers-Lalic, Thomas Wurdinger, Thomas Wurdinger, Thomas Wurdinger, Catherine Alix-Panabières, Catherine Alix-Panabières, Catherine Alix-Panabières   +33 more
doaj   +1 more source

Current detection technologies for circulating tumor cells [PDF]

, 2017
Circulating tumor cells (CTCs) are cancer cells that circulate in the blood stream after being naturally shed from original or metastatic tumors, and can lead to a new fatal metastasis.
Zheyu Shen, Aiguo Wu, Chen, Xiaoyuan, Wu, Aiguo, Xiaoyuan Chen, Shen, Zheyu   +5 more
core   +1 more source

Circulating tumor cells as prognostic biomarkers in glioblastoma. [PDF]

, 2021
Background: Glioblastoma (GBM) is the most common and aggressive type of tumor arising from the central nervous system. GBM remains an incurable disease despite current advancement in therapies, with survival rates of approximately 15 months.
Chua, Benjamin, Warkiani, Majid E, Punyadeera, Chamindie, Hartel, Gunter, Kulasinghe, Arutha, Leo, Paul, Jeffree, Rosalind L, Bark, Juliana Muller, Day, Bryan W   +8 more
core   +1 more source

Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN [PDF]

, 2004
Background: Clinical outcome of patients with head and neck squamous cell carcinoma (SCCHN) depends on several risk factors like the presence of locoregional lymph node or distant metastases, stage, localisation and histologic differentiation of the ...
Walz, A., Kolbow, K., Chaubal, S., Pauli, C., Andratschke, M., Wollenberg, Barbara   +5 more
core   +1 more source

Liquid Biopsy Analysis as a Tool for TKI-Based Treatment in Non-Small Cell Lung Cancer

Cells, 2022
The treatment of non-small cell lung cancer (NSCLC) has recently evolved with the introduction of targeted therapy based on the use of tyrosine kinase inhibitors (TKIs) in patients with certain gene alterations, including EGFR, ALK, ROS1, BRAF, and MET ...
Karolina Buszka, Aliki Ntzifa, Barbara Owecka, Paula Kamińska, Agata Kolecka-Bednarczyk, Maciej Zabel, Michał Nowicki, Evi Lianidou, Joanna Budna-Tukan   +8 more
doaj   +1 more source

The biology of circulating tumor cells [PDF]

Oncogene, 2015
Metastasis is a biologically complex process consisting of numerous stochastic events which may tremendously differ across various cancer types. Circulating tumor cells (CTCs) are cells that are shed from primary tumors and metastatic deposits into the blood stream.
K Pantel, M R Speicher
openaire   +2 more sources

Biomimetic Immuno-Magnetosomes for High-Performance Enrichment of Circulating Tumor Cells [PDF]

, 2016
A novel biomimetic immuno-magnetosome (IMS) is developed by coating a leukocyte membrane (decorated with anti-epithelial cell-adhesion molecule antibody) on a magnetic nanocluster. In addition to the good stability and magnetic controllability, the IMS
Zhao, Dongxu, Yue, Hua, Wang, Shumin, Jin, Yongjie, Xie, Hai-Yan, Wei, Wei, Wang, Shuang, Gao, Xiaoyong, Qiao, Chenmeng, Ma, Guanghui, Xiong, Ke   +10 more
core   +1 more source

Circulating Tumor Cells and PET [PDF]

Journal of Nuclear Medicine, 2011
Understanding the distinct molecular features of solid tumors provides the opportunity to develop more targeted and effective therapies. The evaluation and monitoring of these therapies require sophisticated laboratory and imaging technologies to detect potential benefit not necessarily translating into significant changes in tumor size.
Jian Q, Yu, Massimo, Cristofanilli
openaire   +2 more sources